Search

for
Search:

Sort by

Research

60-90 / 1000+ results

Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women

research Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women

3 citations , May 2018 in “Reproductive Sciences”

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Efficacy and Tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-Blind Placebo-Controlled Trial

research Efficacy and tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-blind Placebo-controlled Trial

1 citations , January 2005 in “임상약리학회지”

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

research Review of the Literature: A Placebo Controlled Split Scalp Study of PRP for Male Pattern Baldness

November 2015 in “Hair transplant forum international”

PRP may help with hair regrowth in male pattern baldness, but more research is needed.

research Faculty Opinions recommendation of Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia.

May 2016 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

research Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.

February 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

research Efficacy and tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia-A Randomized Double-blind Placebo-controlled Trial

January 2005 in “Translational and Clinical Pharmacology”

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

Supplementary Material for: Turpentine Ointment for the Treatment of Folliculitis – An Open, Prospective, Randomized, Placebo- and Comparator-Controlled Multicenter Trial

research Supplementary Material for: Turpentine ointment for the treatment of folliculitis – an open, prospective, randomized, placebo- and comparator-controlled multicenter trial

January 2024 in “Figshare”

Turpentine ointment is effective and safe for treating folliculitis.

Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double-Blind, Placebo-Controlled Trial

research Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial1

94 citations , January 2000 in “The Journal of Clinical Endocrinology and Metabolism”

Spironolactone most effective for hirsutism, but has side effects.

Curcuma Aeruginosa, A Novel Botanically Derived 5α-Reductase Inhibitor In The Treatment Of Male-Pattern Baldness: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

research Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study

34 citations , July 2011 in “Journal of Dermatological Treatment”

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of a Marine Complex Supplement to Promote Hair Growth in Men with Thinning Hair

research A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair

25 citations , August 2016 in “Journal of Cosmetic Dermatology”

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.

A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair

research A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair

22 citations , January 2015 in “Dermatology Research and Practice”

An extra-strength marine protein supplement helped increase hair growth and decrease hair shedding in women with thinning hair.

A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men

research A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men

19 citations , January 2015 in “Skin Pharmacology and Physiology”

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

research Efficacy and safety of minoxidil 3% lotion for beard enhancement: A randomized, double‐masked, placebo‐controlled study

9 citations , February 2016 in “The Journal of Dermatology”

Minoxidil 3% lotion is effective and safe for increasing beard hair count.

research Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial

3 citations , October 2021 in “Clinical, Cosmetic and Investigational Dermatology”

Setipiprant did not significantly improve hair growth in men with hair loss.

Efficacy and Safety of Topical Finasteride Spray Solution in the Treatment of Chinese Men with Androgenetic Alopecia: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

research Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study

March 2025 in “Chinese Medical Journal”

Topical finasteride effectively and safely increases hair growth in men with hair loss.

Enabling Finasteride 1 mg Users to Further Improve Hair Pattern: A Randomized, Double-Blind, Placebo-Controlled Trial of a Novel Product

research Enabling finasteride 1 mg users to further improve hair pattern: A randomized, double-blind, placebo-controlled trial of a novel product

March 2014 in “Journal of The American Academy of Dermatology”

The new topical product combined with finasteride significantly increased hair thickness without side effects.

A Phase IIA Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of the Selective Androgen Receptor Modulator (SARM), MK-0773 in Female Participants with Sarcopenia

research A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

211 citations , May 2013 in “Journal of Nutrition Health & Aging”

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

research Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia

87 citations , September 2016 in “Dermatologic Surgery”

PRP shows potential for treating female hair loss, but more research needed.

research Antihirsutism activity of Fennel (fruits of Foeniculum vulgare) extract – A double-blind placebo controlled study

59 citations , January 2003 in “Phytomedicine”

Fennel extract cream can reduce hair thickness in people with excessive hair growth.

Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial

research Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial

19 citations , December 2021 in “Cureus”

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

research Efficacy and Tolerability of Hairgain® in Individuals with Hair Loss: A Placebo-Controlled, Double-Blind Study

18 citations , February 2001 in “Journal of International Medical Research”

Hairgain® significantly increased hair growth and was well-tolerated by individuals with hair loss.

research A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Anti-Skin-Aging Effect of LactoSporin – The Extracellular Metabolite from Bacillus coagulans (Weizmannia coagulans) MTCC 5856 in Healthy Female Volunteers

16 citations , March 2023 in “Clinical Cosmetic and Investigational Dermatology”

LactoSporin cream reduces wrinkles and improves skin texture safely.

Evaluation of Platelet-Rich Plasma on Hair Regrowth and Lesional T-Cell Cytokine Expression in Alopecia Areata: A Randomized Observer-Blinded, Placebo-Controlled, Split-Head Pilot Study

research Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: A randomized observer-blinded, placebo-controlled, split-head pilot study

9 citations , December 2020 in “Journal of The American Academy of Dermatology”

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

research Platelet-rich Plasma for Androgenetic Alopecia Treatment: A Randomized Placebo-controlled Pilot Study

8 citations , January 2020 in “Acta dermato-venereologica”

PRP injections did not significantly improve hair growth.

research A double-blind, placebo-controlled study with Kevis lotion

4 citations , January 1989

research Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia

3 citations , May 2017 in “Dermatologic Surgery”

PRP may help treat female hair loss, but more research needed.

research Capryloyl glycine and soy isoflavonoids in hypertrichosis: An experimental and placebo‐controlled clinical study

1 citations , April 2021 in “Journal of Cosmetic Dermatology”

The cream effectively reduced hair growth on forearms.

research Amaranthus Extract Promotes Healthy Follicles and Anagen Hair Density-A Randomized Placebo-Controlled, Double-Blinded Study.

October 2025 in “PubMed”

Amaranthus extract cream safely boosts hair growth in men with hair loss.

research A Randomized, Placebo-controlled Clinical Study Evaluating a Dietary Supplement for Hair Growth.

November 2024 in “PubMed”

The supplement improved hair density and was safe to use.

An Oral French Maritime Pine Bark Extract Improves Hair Density in Menopausal Women: A Randomized, Placebo-Controlled, Double-Blind Intervention Study

research An oral French maritime pine bark extract improves hair density in menopausal women: A randomized, placebo‐controlled, double blind intervention study

January 2023 in “Health science reports”

French maritime pine bark extract significantly increased hair density in menopausal women.

← Previous page Next page →